Abstract

Multisystem Inflammatory Syndrome in Children (MIS-C) is a rare manifestation of Severe Acute Respiratory Syndrome-CoronaVirus-2 (SARS-CoV-2) infection that can result in increased morbidity and mortality. Mounting evidence describes sex disparities in the clinical outcomes of coronavirus disease 2019 (COVID-19). However, there is a lack of information on sex-specific differences in immune responses in MIS-C. This study is an observational and cross-sectional study and we wanted to examine immune parameters such as cytokines, chemokines, acute phase proteins (APPs), growth factors, microbial translocation markers (MTMs), complement components and matrix metalloproteinases (MMPs) in MIS-C children, based on sex. Male children were associated with heightened levels of pro-inflammatory cytokines—IFNγ, IL-2, TNFα, IL-1α, IL-1β, IL-6, IL-12, G-CSF and GM-CSF, chemokines-CCL2, CCL11, CXCL1, CXCL8 and CXCL10, acute phase proteins-α-2M, CRP, growth factors VEGF and TGFα, microbial translocation markers- iFABP, LBP, EndoCAb, complement components—C1q, MBL and C3 and matrix metalloproteinases MMP-8 and MMP-9 compared to female children with MIS-C. These results indicate that the heightened immune response in males is a characteristic feature of MIS-C. These findings might explain the differential disease pathogenesis in males compared to females with MIS-C and facilitate a deeper understanding of this disease.

Details

Title
Sex-specific differences in systemic immune responses in MIS-C children
Author
Rajamanickam, Anuradha 1 ; Kumar, Nathella Pavan 2 ; Venkataraman, Aishwarya 2 ; Varadarjan, Poovazhagi 3 ; Selladurai, Elilarasi 3 ; Sankaralingam, Thangavelu 4 ; Thiruvengadam, Kannan 2 ; Selvam, Ramya 4 ; Thimmaiah, Akshith 4 ; Natarajan, Suresh 5 ; Ramaswamy, Ganesh 5 ; Putlibai, Sulochana 6 ; Sadasivam, Kalaimaran 6 ; Sundaram, Balasubramanian 6 ; Hissar, Syed 2 ; Ranganathan, Uma Devi 2 ; Babu, Subash 7 

 National Institutes of Health-National Institute for Research in Tuberculosis – International Center for Excellence in Research, Chennai, India (GRID:grid.417330.2) (ISNI:0000 0004 1767 6138) 
 National Institute for Research in Tuberculosis, Chennai, India (GRID:grid.417330.2) (ISNI:0000 0004 1767 6138) 
 Institute of Child Health and Hospital for Children, Chennai, India (GRID:grid.416256.2) (ISNI:0000 0001 0669 1613) 
 Dr. Mehta’s Children’s Hospital, Chennai, India (GRID:grid.459764.d) (ISNI:0000 0004 1803 4559) 
 Rainbow Children’s Hospital, Chennai, India (GRID:grid.464660.6) (ISNI:0000 0004 1801 0717) 
 Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India (GRID:grid.412931.c) (ISNI:0000 0004 1767 8213) 
 National Institutes of Health-National Institute for Research in Tuberculosis – International Center for Excellence in Research, Chennai, India (GRID:grid.417330.2) (ISNI:0000 0004 1767 6138); National Institutes of Health, Laboratory of Parasitic Diseases, National Institute of Allergy and Infectious Diseases, Bethesda, USA (GRID:grid.94365.3d) (ISNI:0000 0001 2297 5165) 
Pages
1720
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2916553914
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.